Psychiatric disorders are a group of mental illnesses that disturb an individual’s mood, thinking, and behavior, and they represent an important health concern in today’s society. In 2018, one in five US adults (47.6 million) experienced mental illness.
In 2017, Jeffrey Kotas became the first person in North America to participate in a clinical trial investigating the safety of using focused ultrasound to treat obsessive-compulsive disorder (OCD).
In a recent webinar, Renana Eitan, MD, discussed neurosurgical treatment options for treatment-resistant psychiatric disorders and the rationale for introducing focused ultrasound for psychiatry.
Neuromodulation is the reversible stimulation or suppression of neural brain activity, and until now, the exact underlying mechanisms were unclear. But, recent research has shed light on how neuromodulation occurs.
